Campus Alert: Find the latest UMMS campus news and resources at umassmed.edu/coronavirus
UMass Medical School and Massachusetts General Hospital are the first to safely treat two research participants with a synthetic microRNA, delivered into the spinal fluid, designed to silence a human disease-causing gene. Details of the treatment appear in the New England Journal of Medicine.
Read more
Members of your 2020 UMass ALS Cellucci Fund team are as dedicated today as they have ever been to raise money to support ALS research at the University of Massachusetts Medical School. Details about how they will participate in this year's virtual event to come soon.
The goal of the UMass ALS Cellucci Fund is to create a $10 million endowment to seed the boldest research ideas in the interdisciplinary labs under the direction of Robert H. Brown Jr., DPhil, MD, one of the world's foremost authorities on amyotrophic lateral sclerosis (ALS).
